Flunarizine for treatment of chronic migraine: subgroup analysis of patients with/without medication overuse

被引:0
|
作者
Gracia-Naya, M. [1 ]
Hernando-Quintana, N. [2 ]
Latorre-Jimenez, A. M. [3 ]
Rios, C. [4 ]
Santos-Lasaosa, S. [5 ]
Artal-Roy, J. [1 ]
Aznar-Mancebo, N. [1 ]
Garcia-Gomara, M. J. [4 ]
Sanchez-Valiente, S. [5 ]
Mauri-Lerda, J. A. [5 ]
机构
[1] Hosp Univ Miguel Servet, Neurol, Zaragoza, Spain
[2] Hosp Obispo Polanco, Neurol, Teruel, Spain
[3] Hosp San Jorge, Neurol, Huesca, Spain
[4] Hosp Royo Villanova, Neurol, Zaragoza, Spain
[5] Hosp Clin Univ, Neurol, Zaragoza, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PO054
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [1] OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
    HC Diener
    DW Dodick
    RE DeGryse
    CC Turkel
    [J]. The Journal of Headache and Pain, 2013, 14
  • [2] OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
    Diener, H. C.
    Dodick, D. W.
    DeGryse, R. E.
    Turkel, C. C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [3] ONABOTULINUMTOXIN-A FOR TREATMENT OF CHRONIC MIGRAINE: PREEMPT 24-WEEK POOLED SUBGROUP ANALYSIS OF PATIENTS WITHOUT MEDICATION OVERUSE
    Diener, H. -C.
    Dodick, D.
    DeGryse, R.
    Turkel, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 191 - 191
  • [4] Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan Lewis
    Friedman, Deborah I.
    Reuter, Uwe
    Cheng, Sunfa
    Nilsen, Jon
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2019, 92 (20) : E2309 - E2320
  • [5] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
    M Gracia-Naya
    N Hernando-Quintana
    MJ García-Gomara
    S Sánchez-Valiente
    C Ríos
    S Santos-Lasaosa
    JA Mauri
    J Artal-Roy
    AM Latorre-Jimenez
    [J]. The Journal of Headache and Pain, 2013, 14
  • [6] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
    Gracia-Naya, M.
    Hernando-Quintana, N.
    Garcia-Gomara, M. J.
    Sanchez-Valiente, S.
    Rios, C.
    Santos-Lasaosa, S.
    Mauri, J. A.
    Artal-Roy, J.
    Latorre-Jimenez, A. M.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [7] The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Seminerio, Michael J.
    Yang, Ronghua
    Ashina, Sait
    Katsarava, Zaza
    [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [8] The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
    Stephen D. Silberstein
    Joshua M. Cohen
    Michael J. Seminerio
    Ronghua Yang
    Sait Ashina
    Zaza Katsarava
    [J]. The Journal of Headache and Pain, 2020, 21
  • [9] Botulinum neurotoxin type A for treatment of chronic migraine: analysis of the PREEMPT chronic migraine subgroup with baseline acute headache medication overuse
    Silberstein, S. D.
    Blumenfeld, A. M.
    Cady, R. K.
    Turner, I. M.
    Sirimanne, M.
    DeGryse, R. E.
    Turkel, C. C.
    [J]. CEPHALALGIA, 2009, 29 : 31 - 31
  • [10] Botulinum toxin type A in the treatment of chronic migraine without medication overuse
    Freitag, Frederick G.
    Diamond, Seymour
    Diamond, Merle
    Urban, George
    [J]. HEADACHE, 2008, 48 (02): : 201 - 209